Bessemer Group Inc Bausch Health Companies Inc. Transaction History

Bessemer Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$4.58 - $9.21 $7,149 - $14,376	1,561 New	1,561 $10,000
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $1,352 - $1,623	-54 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$27.43 - $32.7 $45,369 - $54,085	-1,654 Reduced 96.84%	54 $2,000
Q1 2021 May 13, 2021	SELL	$21.37 - $34.38 $1,495 - $2,406	-70 Reduced 3.94%	1,708 $54,000
Q2 2020 Aug 05, 2020	BUY	$13.31 - $20.51 $3,993 - $6,153	300 Added 20.3%	1,778 $32,000
Q1 2020 Apr 30, 2020	SELL	$12.98 - $30.25 $6,996 - $16,304	-539 Reduced 26.72%	1,478 $23,000
Q4 2019 Feb 04, 2020	BUY	$18.89 - $31.89 $37,364 - $63,078	1,978 Added 5071.79%	2,017 $60,000
Q3 2019 Nov 07, 2019	SELL	$20.88 - $25.66 $1,044 - $1,283	-50 Reduced 56.18%	39 $1,000
Q1 2019 May 13, 2019	SELL	$20.23 - $26.29 $34,613 - $44,982	-1,711 Reduced 95.06%	89 $2,000
Q4 2018 Feb 12, 2019	BUY	$17.64 - $28.32 $31,752 - $50,976	1,800 New	1,800 $33,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.